{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:48:43Z","timestamp":1790858923074,"version":"4.1.0"},"reference-count":210,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00592","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:39:52Z","timestamp":1586446792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections"],"prefix":"10.3389","volume":"11","author":[{"given":"Sabrina","family":"Schrauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Tschismarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ramsauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1473-3099(16)30010-X","article-title":"Zika virus: history of a newly emerging arbovirus","volume":"16","author":"Wikan","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0006919","DOI":"10.1371\/journal.pntd.0006919","article-title":"Chikungunya as a paradigm for emerging viral diseases: evaluating disease impact and hurdles to vaccine development","volume":"13","author":"Rezza","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.actatropica.2016.11.020","article-title":"The emergence of arthropod-borne viral diseases: a global prospective on dengue, chikungunya and Zika fevers","volume":"166","author":"Mayer","year":"2017","journal-title":"Acta Trop"},{"key":"B4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/femsle\/fnx244","article-title":"Vector-borne diseases and climate change: a European perspective","author":"Semenza","year":"2018","journal-title":"FEMS Microbiol Lett"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0007213","DOI":"10.1371\/journal.pntd.0007213","article-title":"Global expansion and redistribution of Aedes-borne virus transmission risk with climate change","volume":"13","author":"Ryan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. Isolations, I, and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3201\/eid1509.090442","article-title":"Zika virus outside Africa","volume":"15","author":"Hayes","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.3390\/v6114703","article-title":"Flavivirus-mosquito interactions","volume":"6","author":"Huang","year":"2014","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/jir.2017.0011","article-title":"Maternal-fetal transmission of Zika virus: routes and signals for infection","volume":"37","author":"Cao","year":"2017","journal-title":"J Interferon Cytokine Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1402143","DOI":"10.1080\/21688370.2017.1402143","article-title":"Maternal-fetal transmission of the Zika virus: an intriguing interplay","volume":"6","author":"Zanluca","year":"2018","journal-title":"Tissue Barriers."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika virus infection during pregnancy in mice causes placental damage and fetal demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jamapediatrics.2016.3982","article-title":"Characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians","volume":"171","author":"Moore","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B14","first-page":"57","article-title":"Twelve isolations of Zika Virus from Aedes (Stegomyia) Africanus (Theobald) taken in and above a Uganda Forest","volume":"31","author":"Haddow","year":"1964","journal-title":"Bull World Health Organ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1446","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jbspin.2017.01.014","article-title":"Rheumatic manifestations associated with Chikungunya virus infection: a study of 307 patients with 32-month follow-up (RHUMATOCHIK study)","volume":"85","author":"Bouquillard","year":"2018","journal-title":"Joint Bone Spine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.vaccine.2016.03.076","article-title":"Status of research and development of vaccines for chikungunya","volume":"34","author":"Smalley","year":"2016","journal-title":"Vaccine."},{"key":"B19","unstructured":"Autochthonous Transmission of Chikungunya Virus in EU\/EEA, 2007\u201320172017"},{"key":"B20","unstructured":"2019"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(19)32790-4","article-title":"The first local cases of Zika virus in Europe","volume":"394","author":"Brady","year":"2019","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.45.1900655","article-title":"Vector-borne transmission of Zika virus in Europe, southern France, August 2019","volume":"24","author":"Giron","year":"2019","journal-title":"Euro Surveill."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1002611","DOI":"10.1371\/journal.pmed.1002611","article-title":"Sexual transmission of Zika virus and other flaviviruses: a living systematic review","volume":"15","author":"Counotte","year":"2018","journal-title":"PLoS Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 A resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science."},{"key":"B25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nsmb.3352","article-title":"Structure of the immature Zika virus at 9 A resolution","volume":"24","author":"Prasad","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/0470058005.ch3","article-title":"Molecular biology of flaviviruses","author":"Harris","year":"2006","journal-title":"Novartis Found Symp. 277, 23-39; discussion 40"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S935","DOI":"10.1093\/infdis\/jix515","article-title":"Zika Virus Structure, Maturation, and Receptors","volume":"216","author":"Sirohi","year":"2017","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coviro.2017.06.009","article-title":"Flavivirus structural heterogeneity: implications for cell entry","volume":"24","author":"Rey","year":"2017","journal-title":"Curr Opin Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2636","DOI":"10.1371\/journal.pntd.0002636","article-title":"Molecular evolution of Zika virus during its emergence in the 20(th) century","volume":"8","author":"Faye","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika Virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2016.03.012","article-title":"Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells","volume":"18","author":"Nowakowski","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.celrep.2016.12.045","article-title":"Axl mediates Zika virus entry in human glial cells and modulates innate immune responses","volume":"18","author":"Meertens","year":"2017","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"E233","DOI":"10.3390\/v10050233","article-title":"Probing molecular insights into Zika virus(-)host interactions","volume":"10","author":"Lee","year":"2018","journal-title":"Viruses."},{"key":"B35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.chom.2009.04.001","article-title":"Pathogenesis of flavivirus infections: using and abusing the host cell","volume":"5","author":"Fernandez-Garcia","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, (2007)","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2015.10.005","article-title":"Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013","volume":"41","author":"Aubry","year":"2015","journal-title":"Int J Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3201\/eid2110.150847","article-title":"Zika virus outbreak, Bahia, Brazil","volume":"21","author":"Campos","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1590\/0074-02760150192","article-title":"First report of autochthonous transmission of Zika virus in Brazil","volume":"110","author":"Zanluca","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(16)30058-7","article-title":"Guillain-Barre syndrome associated with Zika virus infection","volume":"387","author":"Brasil","year":"2016","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika Virus infection in Pregnant women in Rio de Janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1605367","article-title":"Zika and the risk of Microcephaly","volume":"375","author":"Johansson","year":"2016","journal-title":"N Engl J Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.15585\/mmwr.mm6509e2","article-title":"Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed zika virus transmission during the first trimester of pregnancy - Brazil, 2015","volume":"65","author":"Kleber de Oliveira","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B47","unstructured":"2019"},{"key":"B48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1099\/jgv.0.000381","article-title":"Zika virus: a previously slow pandemic spreads rapidly through the Americas","volume":"97","author":"Gatherer","year":"2016","journal-title":"J Gen Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature22365","article-title":"Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes","volume":"545","author":"Liu","year":"2017","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aam7120","article-title":"A single mutation in the prM protein of Zika virus contributes to fetal microcephaly","volume":"358","author":"Yuan","year":"2017","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2017.07.001","article-title":"The immunopathology of dengue and Zika virus infections","volume":"48","author":"Culshaw","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1172\/JCI84417","article-title":"Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies","volume":"127","author":"Silva","year":"2017","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.antiviral.2015.07.002","article-title":"Chikungunya virus pathogenesis: from bedside to bench","volume":"121","author":"Couderc","year":"2015","journal-title":"Antiviral Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.3390\/v7072792","article-title":"Early events in Chikungunya virus infection-from virus cell binding to membrane fusion","volume":"7","author":"van","year":"2015","journal-title":"Viruses"},{"key":"B56","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","article-title":"Mxra8 is a receptor for multiple arthritogenic alphaviruses","volume":"557","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.antiviral.2015.06.009","article-title":"Cellular and molecular mechanisms of chikungunya pathogenesis","volume":"120","author":"Lum","year":"2015","journal-title":"Antiviral Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1056\/NEJMc1505501","article-title":"Chikungunya Virus infections","volume":"373","author":"Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","article-title":"Global expansion of chikungunya virus: mapping the 64-year history","volume":"58","author":"Wahid","year":"2017","journal-title":"Int J Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7171.1","author":"Petersen","year":"2016","journal-title":"Chikungunya: epidemiology [version 1; referees: 2 approved]"},{"key":"B61","unstructured":"SaudeSdVe 2019"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog"},{"key":"B63","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1128\/JVI.01603-09","article-title":"Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates","volume":"84","author":"Volk","year":"2010","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0004960","DOI":"10.1371\/journal.pntd.0004960","article-title":"Antigenic variation of East\/Central\/South African and Asian Chikungunya Virus genotypes in neutralization by immune sera","volume":"10","author":"Chua","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"02449","DOI":"10.1128\/mBio.02449-17","article-title":"Chikungunya Virus strains show lineage-specific variations in virulence and cross-protective ability in murine and nonhuman primate models","volume":"9","author":"Langsjoen","year":"2018","journal-title":"MBio."},{"key":"B66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika Virus infection in Man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B67","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2017.03.001","article-title":"Zika virus: history, epidemiology, transmission, and clinical presentation","volume":"308","author":"Song","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(16)00502-X","article-title":"Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection","volume":"387","author":"Karimi","year":"2016","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1056\/NEJMc1610613","article-title":"Fatal Zika Virus infection with secondary nonsexual transmission","volume":"375","author":"Swaminathan","year":"2016","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1056\/NEJMc1603618","article-title":"Uveitis associated with Zika Virus infection","volume":"375","author":"Furtado","year":"2016","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMc1602964","article-title":"Zika Virus associated with Meningoencephalitis","volume":"374","author":"Carteaux","year":"2016","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika Virus infects human cortical neural progenitors and attenuates their growth","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1080\/22221751.2019.1637283","article-title":"Zika virus differentially infects human neural progenitor cells according to their state of differentiation and dysregulates neurogenesis through the Notch pathway","volume":"8","author":"Ferraris","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"B74","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.neurol.2016.10.011","article-title":"Guillain-Barre syndrome: 100 years on","volume":"172","author":"Creange","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain-Barre syndrome: a century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/cid\/ciy356","article-title":"Differences in transmission and disease severity between 2 successive waves of Chikungunya","volume":"67","author":"Gordon","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/517537","article-title":"Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients","volume":"44","author":"Borgherini","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MD.0b013e318260b604","article-title":"Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island","volume":"91","author":"Marimoutou","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"B79","unstructured":"Chikungunya: case definitions for acute, atypical and chronic cases Conclusions of an expert consultation, Managua, Nicaragua, 20\u201321 May 20152015"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3201\/eid1212.060710","article-title":"Chikungunya disease outbreak, Reunion Island","volume":"12","author":"Josseran","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1590\/0074-02760170124","article-title":"Increased number of deaths during a chikungunya epidemic in Pernambuco, Brazil","volume":"112","author":"Brito","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0007575","DOI":"10.1371\/journal.pntd.0007575","article-title":"Chikungunya-attributable deaths: a neglected outcome of a neglected disease","volume":"13","author":"Lima Neto","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e2137","DOI":"10.1371\/journal.pntd.0002137","article-title":"Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study","volume":"7","author":"Schilte","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e00009","DOI":"10.1128\/JVI.00009-17","article-title":"Animal models of Zika Virus infection, pathogenesis, and immunity","volume":"91","author":"Morrison","year":"2017","journal-title":"J Virol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.vaccine.2018.01.056","article-title":"Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells","volume":"36","author":"Basu","year":"2018","journal-title":"Vaccine"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e01719","DOI":"10.1128\/MRA.01719-18","article-title":"Complete genome sequence of a colombian Zika Virus strain obtained from BALB\/c mouse brain after intraperitoneal inoculation","volume":"8","author":"Laiton-Donato","year":"2019","journal-title":"Microbiol Resour Announc."},{"key":"B87","doi-asserted-by":"publisher","first-page":"S928","DOI":"10.1093\/infdis\/jix540","article-title":"Nonhuman primate models of Zika Virus infection, immunity, and therapeutic development","volume":"216","author":"Osuna","year":"2017","journal-title":"J Infect Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/v5112643","article-title":"The innate immune playbook for restricting West Nile virus infection","volume":"5","author":"Quicke","year":"2013","journal-title":"Viruses"},{"key":"B89","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2016.03.008","article-title":"Type III interferons produced by human placental trophoblasts confer protection against zika virus infection","volume":"19","author":"Bayer","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","article-title":"The IFITMs inhibit Zika virus replication","volume":"15","author":"Savidis","year":"2016","journal-title":"Cell Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8(+) T cell response during primary Zika virus infection in mice","volume":"21","author":"Elong Ngono","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e00900","DOI":"10.1128\/JVI.00900-17","article-title":"CD8(+) T Cell immune response in immunocompetent mice during Zika Virus infection","volume":"91","author":"Huang","year":"2017","journal-title":"J Virol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e1007237","DOI":"10.1371\/journal.ppat.1007237","article-title":"CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection","volume":"14","author":"Hassert","year":"2018","journal-title":"PLoS Pathog"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1038\/s41467-018-05519-4","article-title":"Critical role of CD4(+) T cells and IFNgamma signaling in antibody-mediated resistance to Zika virus infection","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41564-017-0060-z","article-title":"Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice","volume":"3","author":"Jurado","year":"2018","journal-title":"Nat Microbiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","article-title":"Broadly neutralizing activity of Zika Virus-immune sera identifies a single viral serotype","volume":"16","author":"Dowd","year":"2016","journal-title":"Cell Rep"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"B98","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J Med Virol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","article-title":"Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages","volume":"110","author":"Kreil","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/cid\/cix558","article-title":"Viral load and cytokine response profile does not support antibody-dependent enhancement in dengue-primed Zika virus-infected patients","volume":"65","author":"Terzian","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.immuni.2019.01.005","article-title":"Dengue Virus immunity increases Zika virus-induced damage during pregnancy","volume":"50","author":"Brown","year":"2019","journal-title":"Immunity."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog"},{"key":"B108","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"Akahata","year":"2010","journal-title":"Nat Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","article-title":"A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus","volume":"31","author":"Brandler","year":"2013","journal-title":"Vaccine"},{"key":"B110","doi-asserted-by":"publisher","first-page":"S482","DOI":"10.1093\/infdis\/jiw284","article-title":"Animal Models of Chikungunya Virus Infection and Disease","volume":"214","author":"Haese","year":"2016","journal-title":"J Infect Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/pathogens4030662","article-title":"Nonhuman primate models of chikungunya virus infection and disease (CHIKV NHP model)","volume":"4","author":"Broeckel","year":"2015","journal-title":"Pathogens"},{"key":"B113","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jaci.2015.01.039","article-title":"Control of immunopathology during chikungunya virus infection","volume":"135","author":"Petitdemange","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40475-015-0037-z","article-title":"Protective and pathogenic responses to chikungunya virus infection","volume":"2","author":"Long","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"B115","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1084\/jem.20090851","article-title":"Type I IFN controls chikungunya virus via its action on nonhematopoietic cells","volume":"207","author":"Schilte","year":"2010","journal-title":"J Exp Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1128\/JVI.00956-12","article-title":"Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock","volume":"86","author":"Rudd","year":"2012","journal-title":"J Virol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.4049\/jimmunol.1103185","article-title":"Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection","volume":"188","author":"Schilte","year":"2012","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/infdis\/jiq006","article-title":"The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation","volume":"204","author":"Wauquier","year":"2011","journal-title":"J Infect Dis"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e1006748","DOI":"10.1371\/journal.ppat.1006748","article-title":"Inflammatory monocytes mediate control of acute alphavirus infection in mice","volume":"13","author":"Haist","year":"2017","journal-title":"PLoS Pathog"},{"key":"B120","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41584-019-0276-9","article-title":"Rheumatic manifestations of chikungunya: emerging concepts and interventions","volume":"15","author":"Suhrbier","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.virusres.2013.08.011","article-title":"Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes\/macrophages in CHIKV-induced arthralgia\/arthritis","volume":"177","author":"Phuklia","year":"2013","journal-title":"Virus Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1128\/JVI.02603-09","article-title":"Chikungunya virus arthritis in adult wild-type mice","volume":"84","author":"Gardner","year":"2010","journal-title":"J Virol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.vaccine.2017.07.065","article-title":"Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"B124","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1016\/j.vaccine.2018.10.033","article-title":"Defining a correlate of protection for chikungunya virus vaccines","volume":"37","author":"Milligan","year":"2018","journal-title":"Vaccine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e0003764","DOI":"10.1371\/journal.pntd.0003764","article-title":"High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines","volume":"9","author":"Yoon","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e0004281","DOI":"10.1371\/journal.pntd.0004281","article-title":"Long-lasting immune protection and other epidemiological findings after Chikungunya emergence in a Cambodian Rural Community, April (2012)","volume":"10","author":"Galatas","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B127","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41426-017-0010-0","article-title":"Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community","volume":"7","author":"Auerswald","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"B128","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/600381","article-title":"Prophylaxis and therapy for Chikungunya virus infection","volume":"200","author":"Couderc","year":"2009","journal-title":"J Infect Dis"},{"key":"B130","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1128\/JVI.01032-14","article-title":"Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes","volume":"88","author":"Pal","year":"2014","journal-title":"J Virol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e0005637","DOI":"10.1371\/journal.pntd.0005637","article-title":"Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques","volume":"11","author":"Broeckel","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.1202177","article-title":"A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3389\/fimmu.2019.02563","article-title":"Vaccine-induced skewing of T cell responses protects against chikungunya virus disease","volume":"10","author":"Broeckel","year":"2019","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"15743","DOI":"10.1038\/ncomms15743","article-title":"DNA vaccination protects mice against Zika virus-induced damage to the testes","volume":"8","author":"Griffin","year":"2017","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708120","article-title":"Safety and immunogenicity of an anti-Zika virus DNA vaccine - preliminary report","author":"Tebas","year":"2017","journal-title":"N Engl J Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"B137","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/infdis\/jiz338","article-title":"Protective efficacy of nucleic acid vaccines against transmission of zika virus during pregnancy in mice","volume":"220","author":"Jagger","year":"2019","journal-title":"J Infect Dis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet."},{"key":"B141","doi-asserted-by":"publisher","first-page":"46375","DOI":"10.1038\/srep46375","article-title":"Protective efficacy of Zika vaccine in AG129 mouse model","volume":"7","author":"Sumathy","year":"2017","journal-title":"Sci Rep"},{"key":"B142","doi-asserted-by":"publisher","first-page":"16509","DOI":"10.1038\/s41598-018-34735-7","article-title":"Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice","volume":"8","author":"Baldwin","year":"2018","journal-title":"Sci Rep"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e01485","DOI":"10.1128\/JVI.01485-18","article-title":"A measles virus-based vaccine candidate mediates protection against Zika virus in an allogeneic mouse pregnancy model","volume":"93","author":"Nurnberger","year":"2019","journal-title":"J Virol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B146","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.vaccine.2019.04.013","article-title":"Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice","volume":"37","author":"Lecouturier","year":"2019","journal-title":"Vaccine"},{"key":"B148","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","article-title":"An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors","volume":"19","author":"Shan","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B149","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","article-title":"A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage","volume":"8","author":"Shan","year":"2017","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.08.056","article-title":"A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity","volume":"36","author":"Zou","year":"2018","journal-title":"EBioMedicine"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e02134","DOI":"10.1128\/mBio.02134-16","article-title":"Understanding Zika virus stability and developing a chimeric vaccine through functional analysis","volume":"8","author":"Xie","year":"2017","journal-title":"MBio."},{"key":"B152","doi-asserted-by":"publisher","first-page":"eaao4163","DOI":"10.1126\/scitranslmed.aao4163","article-title":"Durability and correlates of vaccine protection against Zika virus in rhesus monkeys","volume":"9","author":"Abbink","year":"2017","journal-title":"Sci Transl Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e0202820","DOI":"10.1371\/journal.pone.0202820","article-title":"Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge","volume":"13","author":"Cox","year":"2018","journal-title":"PLoS One."},{"key":"B154","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/infdis\/jiy187","article-title":"Immunization with a novel human type 5 Adenovirus-Vectored vaccine expressing the premembrane and envelope proteins of Zika virus provides consistent and sterilizing protection in multiple immunocompetent and immunocompromised animal models","volume":"218","author":"Guo","year":"2018","journal-title":"J Infect Dis"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1038\/s41467-018-04859-5","article-title":"Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors","volume":"9","author":"Lopez-Camacho","year":"2018","journal-title":"Nat Commun."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/s41467-018-03662-6","article-title":"A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses","volume":"9","author":"Prow","year":"2018","journal-title":"Nat Commun"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e01722","DOI":"10.1128\/JVI.01722-17","article-title":"Recombinant Chimpanzee adenovirus vaccine AdC7-M\/E protects against Zika Virus infection and testis damage","volume":"92","author":"Xu","year":"2018","journal-title":"J Virol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.4049\/jimmunol.1602180","article-title":"Cutting edge: innate immune augmenting vesicular stomatitis virus expressing Zika virus proteins confers protective immunity","volume":"198","author":"Betancourt","year":"2017","journal-title":"J Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"11043","DOI":"10.1038\/s41598-018-29401-x","article-title":"A VSV-based Zika virus vaccine protects mice from lethal challenge","volume":"8","author":"Emanuel","year":"2018","journal-title":"Sci Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e0005608","DOI":"10.1371\/journal.pntd.0005608","article-title":"Zika virus-like particle (VLP) based vaccine","volume":"11","author":"Boigard","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B161","doi-asserted-by":"publisher","first-page":"e00834","DOI":"10.1128\/JVI.00834-17","article-title":"Development of virus-Like-Particle vaccine and reporter assay for Zika virus","volume":"91","author":"Garg","year":"2017","journal-title":"J Virol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"13005","DOI":"10.1128\/JVI.01780-12","article-title":"Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development","volume":"86","author":"Kam","year":"2012","journal-title":"J Virol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nmni.2015.04.002","article-title":"Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy","volume":"7","author":"Pierro","year":"2015","journal-title":"New Microbes New Infect"},{"key":"B164","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.107.3.643","article-title":"Production and evaluation of a formalin-killed Chikungunya vaccine","volume":"107","author":"Harrison","year":"1971","journal-title":"J Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"Kumar","year":"2012","journal-title":"Vaccine"},{"key":"B166","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"B167","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1016\/j.vaccine.2012.08.025","article-title":"US Military contributions to the global response to pandemic chikungunya","volume":"30","author":"Hoke","year":"2012","journal-title":"Vaccine"},{"key":"B168","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1016\/j.vaccine.2012.04.099","article-title":"Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine","volume":"30","author":"Partidos","year":"2012","journal-title":"Vaccine"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/JVI.03453-13","article-title":"Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice","volume":"88","author":"Hallengard","year":"2014","journal-title":"J Virol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1128\/JVI.01926-14","article-title":"Prime-boost immunization strategies against Chikungunya virus","volume":"88","author":"Hallengard","year":"2014","journal-title":"J Virol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e83527","DOI":"10.1172\/jci.insight.83527","article-title":"Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus","volume":"2","author":"Roques","year":"2017","journal-title":"JCI Insight"},{"key":"B172","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","volume":"392","author":"Reisinger","year":"2018","journal-title":"Lancet."},{"key":"B174","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/infdis\/jiz202","article-title":"Immunogenicity and efficacy of a measles virus-vectored Chikungunya vaccine in nonhuman primates","volume":"220","author":"Rossi","year":"2019","journal-title":"J Infect Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"E231","DOI":"10.3390\/pathogens8040231","article-title":"A single and un-adjuvanted dose of a chimpanzee adenovirus-vectored vaccine against Chikungunya virus fully protects mice from lethal disease","volume":"8","author":"Campos","year":"2019","journal-title":"Pathogens."},{"key":"B176","doi-asserted-by":"publisher","first-page":"E322","DOI":"10.3390\/v11040322","article-title":"Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus","volume":"11","author":"Lopez-Camacho","year":"2019","journal-title":"Viruses."},{"key":"B177","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/infdis\/jiw431","article-title":"A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all Chikungunya virus genotypes","volume":"214","author":"Goo","year":"2016","journal-title":"J Infect Dis"},{"key":"B179","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4269\/ajtmh.1967.16.786","article-title":"Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues","volume":"16","author":"Harrison","year":"1967","journal-title":"Am J Trop Med Hyg"},{"key":"B180","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"Tiwari","year":"2009","journal-title":"Vaccine"},{"key":"B181","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of chikungunya virus for use in vaccine production","volume":"4","author":"Levitt","year":"1986","journal-title":"Vaccine."},{"key":"B182","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1128\/JVI.06449-11","article-title":"Attenuation of Chikungunya virus vaccine strain 181\/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein","volume":"86","author":"Gorchakov","year":"2012","journal-title":"J Virol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/infdis\/jiu014","article-title":"Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose","volume":"209","author":"Roy","year":"2014","journal-title":"J Infect Dis"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"Plante","year":"2011","journal-title":"PLoS Pathog"},{"key":"B185","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"key":"B186","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.virol.2015.03.013","article-title":"Innate immune recognition of DNA: a recent history","author":"Dempsey","year":"2015","journal-title":"Virology."},{"key":"B187","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","author":"Kell","year":"2015","journal-title":"Virology."},{"key":"B188","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.immuni.2010.10.004","article-title":"Immunologic basis of vaccine vectors","volume":"33","author":"Liu","year":"2010","journal-title":"Immunity"},{"key":"B189","doi-asserted-by":"publisher","first-page":"e3101","DOI":"10.1371\/journal.pntd.0003101","article-title":"Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge","volume":"8","author":"van den Doel","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B190","doi-asserted-by":"publisher","first-page":"e2970","DOI":"10.1371\/journal.pntd.0002970","article-title":"A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice","volume":"8","author":"Weger-Lucarelli","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B191","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1128\/JVI.03418-13","article-title":"A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection","volume":"88","author":"Garcia-Arriaza","year":"2014","journal-title":"J Virol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1128\/JVI.01860-12","article-title":"A chimeric vesiculo\/alphavirus is an effective alphavirus vaccine","volume":"87","author":"Chattopadhyay","year":"2013","journal-title":"J Virol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"B194","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"B195","doi-asserted-by":"publisher","first-page":"9249","DOI":"10.1128\/JVI.00844-11","article-title":"Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"Erasmus","year":"2017","journal-title":"Nat Med"},{"key":"B197","doi-asserted-by":"publisher","first-page":"e2124","DOI":"10.1371\/journal.pntd.0002124","article-title":"Effective chikungunya virus-like particle vaccine produced in insect cells","volume":"7","author":"Metz","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B198","doi-asserted-by":"publisher","first-page":"e0004782","DOI":"10.1371\/journal.pntd.0004782","article-title":"Expression and characterization of yeast derived Chikungunya virus like particles (CHIK-VLPs) and its evaluation as a potential vaccine candidate","volume":"10","author":"Saraswat","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B199","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.vaccine.2020.01.091","article-title":"Bacteriophage Qbeta virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus","volume":"38","author":"Basu","year":"2020","journal-title":"Vaccine."},{"key":"B200","doi-asserted-by":"publisher","first-page":"e928","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B201","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/vim.2012.0061","article-title":"Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine","volume":"26","author":"Bao","year":"2013","journal-title":"Viral Immunol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/infdis\/jiu114","article-title":"DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice","volume":"209","author":"Tretyakova","year":"2014","journal-title":"J Infect Dis"},{"key":"B203","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/1743-422X-8-353","article-title":"Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells","volume":"8","author":"Metz","year":"2011","journal-title":"Virol J"},{"key":"B204","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"Khan","year":"2012","journal-title":"Virus Res"},{"key":"B205","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1016\/j.vaccine.2013.09.045","article-title":"Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits","volume":"31","author":"Metz","year":"2013","journal-title":"Vaccine."},{"key":"B206","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.vaccine.2018.12.040","article-title":"Demonstrating vaccine effectiveness during a waning epidemic: a WHO\/NIH meeting report on approaches to development and licensure of Zika vaccine candidates","volume":"37","author":"Vannice","year":"2019","journal-title":"Vaccine"},{"key":"B207","doi-asserted-by":"publisher","first-page":"mxz012","DOI":"10.1093\/epirev\/mxz012","article-title":"CEPI: driving progress towards epidemic preparedness and response","author":"Gouglas","year":"2019","journal-title":"Epidemiol Rev."},{"key":"B208","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coi.2018.04.019","article-title":"Sustainable vaccine development: a vaccine manufacturer's perspective","volume":"53","author":"Rappuoli","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1542\/peds.2010-1722E","article-title":"Food and drug administration regulation and evaluation of vaccines","volume":"127","author":"Marshall","year":"2011","journal-title":"Pediatrics"},{"key":"B210","year":"2018","journal-title":"WHO consultation on Chikungunya vaccine Evaluation."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T19:08:48Z","timestamp":1696014528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":210,"alternative-id":["10.3389\/fimmu.2020.00592"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00592","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"article-number":"592"}}